Skip to content

Medical-device intelligence

MSV: System,Test,Antibodies,B2 - Glycoprotein I (B2 - Gpi)

FDA product code MSV: System,Test,Antibodies,B2 - Glycoprotein I (B2 - Gpi). View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
MSV
FDA device name
System,Test,Antibodies,B2 - Glycoprotein I (B2 - Gpi)
Device class
2
Regulation number
866.5660
Medical specialty
Immunology
Review panel
IM

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore immunology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

46 clearance records and 1 recall records in the covered releases, across 19 source company names and 1 product codes. Dated history runs from Jun 24, 1997 to Feb 6, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202610
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
MSV · System,Test,Antibodies,B2 - Glycoprotein I (B2 - Gpi)461

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

47 matching records
Device / recordCompany in FDA recordSourceSource date
Aptiva APS IgA ReagentK243979 · MSVInova Diagnostics, Inc.510(k)Feb 6, 2026FDA decision date
EliA B2-Glycoprotein I IgA Immunoassay, EliA Cardiolipin IgA ImmunoassayK181329 · MSVPhadia AB510(k)Jun 25, 2018FDA decision date
ImmuLisa Enhanced B2GP1 IgA Antibody ELISA, ImmuLisa Enhanced B2GP1 IgG Antibody ELISA, ImmuLisa Enhanced B2GP1 IgM Antibody ELISA, ImmuLisa Enha…K162788 · MSVImmco Diagnostics, Inc.510(k)Jun 19, 2017FDA decision date
QUANTA Flash B2GP1-Domain1, QUANTA Flash B2GP1-Domain1 Controls, HemosIL AcuStar Anti-B2GPI Domain 1, HemosIL AcuStar Anti-B2GPI Domain 1 Control…K152875 · MSVInova Diagnostics, Inc.510(k)Dec 21, 2015FDA decision date
QUANTA FLASH ¿2GP1-DOMAIN1; CONTROLS, HEMOSIL ACUSTAR ANTI-¿2GPI DOMAIN1; CONTROLS.K141274 · MSVInova Diagnostics, Inc.510(k)Feb 13, 2015FDA decision date
ELIA B2-GLYCOPROTEIN I IGA IMMUNOASSAYK112414 · MSVPhadia US, Inc.510(k)Jun 22, 2012FDA decision date
HEMOSIL ACUSTAR ANTI-B2 GLYCOPROTEIN-I; IGG, IGM, IGG CONTROLS, IGM CONTROLSK091556 · MSVInstrumentation Laboratory CO510(k)May 21, 2010FDA decision date
THERATEST EL-BETA2GPI (IGM-IGG-IGA), THERATEST EL--BETA2GPI SCRK092757 · MSVThera-Test Laboratories, Inc.510(k)Oct 9, 2009FDA decision date
IGG ANTI-ATHEROX TEST KITK072032 · MSVCorgenix, Inc.510(k)Apr 4, 2008FDA decision date
AESKULSKA BETA2-GLYCO-AK062217 · MSVAesku, Inc.510(k)Dec 13, 2006FDA decision date
Data reduction program written for a specific automated microtiter plate instrument (Bio-Tek ELx800) reader) for use with Diastat Anti-Beta2 Glyc…Z-0674-05 · MSVDiasorin Inc.RecallApr 6, 2005FDA classification date
VARELISA B2 GLYCOPROTEIN I IGG ANTIBODIES, MODELS 18748 AND 18796K040449 · MSVPharmacia Deutschland GmbH510(k)May 11, 2004FDA decision date
VARELISA B2 GLYCOPROTEIN I IGA ANTIBODIES, MODELS 18948 AND 18996K040450 · MSVPharmacia Deutschland GmbH510(k)May 11, 2004FDA decision date
VARELISA B2 GLYCOPROTEIN I IGM ANTIBODIES, MODELS 18848 AND 18896K040451 · MSVPharmacia Deutschland GmbH510(k)May 11, 2004FDA decision date
VARELISA B2 GLYCOPROTEIN I ANTIBODIES SCREEN, MODELS 19048 AND 19096K040452 · MSVPharmacia Deutschland GmbH510(k)May 11, 2004FDA decision date
IMMULISA ANTI-BETA2 GLYCOPROTEIN I (B2GP1) IGG ELISAK030701 · MSVImmco Diagnostics, Inc.510(k)Sep 9, 2003FDA decision date
IMMULISA ANTI-BETA2 GLYCOPROTEIN I (B2GP1) IGM ELISAK030702 · MSVImmco Diagnostics, Inc.510(k)Sep 9, 2003FDA decision date
REAADS IGM ANTI-B2GPI TEST KIT, MODEL 038-001K031208 · MSVCorgenix, Inc.510(k)Jul 7, 2003FDA decision date
DIASTAT ANTI-B2 GLYCOPROTEIN 1 IGM, MODEL FBGP 100MK031177 · MSVAxis-Shield Diagnostics, Ltd.510(k)Jun 19, 2003FDA decision date
AUTOSTAT II ANTI-B-2 GLYCOPROTEIN I IGA ELISAK030397 · MSVHycor Biomedical , Ltd.510(k)Mar 21, 2003FDA decision date
AUTOSTAT II ANTI-B-2 GLYCOPROTEIN-I IGM ELISAK022944 · MSVHycor Biomedical, Inc.510(k)Dec 18, 2002FDA decision date
AUTOSTAT II ANTI-B-2 GLYCOPROTEIN I IGG ELISAK022945 · MSVHycor Biomedical, Inc.510(k)Dec 18, 2002FDA decision date
QAB2A IGM ELISA KIT HRPK021610 · MSVCheshire Diagnostics , Ltd.510(k)Jul 12, 2002FDA decision date
QAB2A IGG ELISA KIT HRPK021611 · MSVCheshire Diagnostics , Ltd.510(k)Jul 12, 2002FDA decision date
QAB2A IGG ELISA KITK020695 · MSVCheshire Diagnostics , Ltd.510(k)Apr 19, 2002FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗